Pune, India, Oct. 06, 2022 (GLOBE NEWSWIRE) -- The global veterinary therapeutics market is projected to grow at a significant rate on account of rising demand for meat and meat products. Fortune Business Insights in its new report, titled “Veterinary Therapeutics Market Forecast, 2025” finds that the growing population across the world is positively impacting the veterinary therapeutics market. In 2017, the global market for veterinary therapeutics was valued at US$ 35,005.2 Mn and is projected to reach a value of US$ 54,968.3 Mn by 2025. Furthermore, the report predicts the global market to expand at a CAGR of 5.8% during the forecast period.
Veterinary therapeutic drugs are expected to emerge dominant in the global veterinary therapeutics market by 2025. The segment covered a share of 51.1% in the year 2017 in the global market. This is ascribable to the rising use of therapeutic drugs on pets and growing awareness about animal health. In addition to this, fast approval on new products is also driving the therapeutic drugs segment. However, increasing number of restrictions on the use of antibiotics may offset the segment’s growth. Vaccines are also projected to gain popularity among other veterinary therapeutic products in the upcoming years. The rising need for treating diseases in animals is the major factor driving this segment.
Among regions, North America is expected to lead the global veterinary therapeutics market. The region market was valued at US$ 11,124.6 Mn in the year 2017. The increasing adoption of veterinary products in this region is likely to create ample growth opportunities for the veterinary therapeutics market until 2025. Besides North America, Asia Pacific is anticipated to show considerable growth in response to growing demand for of vaccines and drugs in the region. Rising livestock population in countries such as China and India will drive the veterinary therapeutics and medicine in Asia Pacific.
Request a Sample Copy of the Research Report
Report Scope & Segmentation
| Report Coverage | Details |
| Forecast Period | 2018 to 2025 |
| Forecast Period 2018 to 2025 CAGR | 5.8% |
| 2025 Value Projection | USD 54,968 Million |
| Base Year | 2017 |
| Market Size in 2017 | USD 35,005.2 Million |
| Historical Data for | 2014 to 2016 |
| No. of Pages | 150 |
| Key Market Players | Zoetis, Intervet Inc., Vetoquinol S.A., Elanco, Merial, IDEXX Laboratories, Inc. |
| Veterinary Therapeutics Market Growth Drivers | Increasing Access to Treatment for Companion Animals to Propel the Market |
| Strict Government Rules May Restrict the Market | |
| Focus on Expanding Product Portfolio May Offer Promising Growth Opportunities |
To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit:
https://www.fortunebusinessinsights.com/industry-reports/veterinary-therapeutics-market-100138
Increasing Access to Treatment for Companion Animals to Propel the Market
“The increasing research and development (R&D) activities in the veterinary therapeutics area will create ample opportunities for the market’s growth,” stated a lead analyst at Fortune Business Insights. “This has further resulted in the discovery of novel treatment and surgical capabilities for companion animals, which will positively impact the market’s growth,” he added. Also, the rising population across the world, combined with rising demand for food, will act as a chief growth driver of the global veterinary therapeutics market. In addition to this, the rising demand for veterinary therapeutics treatment is an outcome of the growing preference among consumers for livestock, dairy products, and meat products. This is further encouraging companies to introduce novel veterinary therapeutics. Pet ownership is increasing in developing and developed countries, paving way for the entry of veterinary therapeutics and pharmacology. Moreover, there is a rising demand for high quality meat protein especially in developing countries. This factors are likely to increasing the demand for dairy and meat products. The use of veterinary therapeutic services and medication is increasing with the rising emphasis on prevention of diseases among animals and ensure their wellness of animals by veterinarians. Overall, the above factors, coupled with the rising awareness about veterinary healthcare, are encouraging the growth of the veterinary therapeutics market.
Quick Buy
https://www.fortunebusinessinsights.com/checkout-page/100138
Strict Government Rules May Restrict the Market
Certain factors may hamper the growth of the veterinary therapeutics market. The chief factor likely to restrict the market’s growth is implementation of stringent government regulations. In addition to this, minimum returns on research and development activities associated with veterinary therapeutic drug monitoring may impede the growth of the veterinary therapeutics market.
Segmentations:
| Segmentation | By Product Type
|
By Animal Type
|
Focus on Expanding Product Portfolio May Offer Promising Growth Opportunities
Some of the leading players operational in the global market for veterinary therapeutics are
- Zoetis
- Intervet Inc.
- Vetoquinol S.A.
- Elanco
- Merial
- IDEXX Laboratories, Inc.
- Bayer AG
- Boehringer Ingelheim International GmbH
- Virbac
- Ceva
In 2017, Zoetis was the leading player in the global market with the presence of strong product portfolio. One of the chief strategies adopted by companies is strengthening their product portfolio by introducing new products. This is projected to generate huge growth opportunities for the global veterinary therapeutics market during the forecast period between 2017 and 2025.
Table of Content
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Pipeline Analysis
- Regulatory Scenario for Key Countries
- Pricing Analysis
- Key Industry Developments
- Overview of Animal Diseases by Key Countries
- Snapshot on the Novel & Upcoming Therapies
- Overview of Treatment Plans for Different Animal Diseases
- Overview of Incidence & Prevalence of Animal Diseases
- Global Veterinary Therapeutics Market Analysis, Insights and Forecast, 2014-2025
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Product
- Drugs
- Vaccines
- Feed Additives
- Others
- Market Analysis, Insights and Forecast – By Animal Type
- Companion
- Livestock
- Market Analysis, Insights and Forecast – By Route of Administration
- Oral
- Parenteral
- Topical
- Market Analysis, Insights and Forecast – By Distribution Channels
- Veterinary Hospitals
- Veterinary Clinics
- Pharmacies & Drug Stores
- Others
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
ToC Continued…!
Have Any Query? Ask Our Experts
Frequently Asked Questions
What was the size of the global veterinary therapeutics market in 2017?
According to Fortune Business Insights, the veterinary therapeutics market was valued at USD 35.00 Billon in 2017.
How much will the global veterinary therapeutics market be worth in the future?
Fortune Business Insights has estimated the value of the veterinary therapeutics market at USD 54.96 Billion in 2025.
About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Address:
Fortune Business Insights Pvt. Ltd.9th Floor, Icon Tower, Baner –
Mahalunge Road, Baner, Pune-411045,
Maharashtra, India.
Phone:
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com
